SCHEMBL4904186

SCHEMBL4904186

[CH2]CCCCC(C)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17376783 0.91 — —
SCHEMBL27871146 0.78 — —
SCHEMBL632214 0.75 — —
SCHEMBL9361770 0.73 PAOX (0.31) —
SCHEMBL987504 0.73 — —
SCHEMBL1694201 0.73 PAOX (0.31) —
SCHEMBL1015557 0.73 — —
SCHEMBL10424508 0.73 PAOX (0.31) —
SCHEMBL9365366 0.73 PAOX (0.31) —
SCHEMBL9362505 0.73 PAOX (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117664949-A Detection method of surface-enhanced Raman nano particles and fentanyl substances 深圳海关工业品检测技术中心 2024-03-08 — — CN disclosed
US-20080193481-A1 Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines GOVERNORS OF THE UNIVERSITY OF ALBERTA 2008-08-14 — — US disclosed
EP-1863536-A1 SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES The Governors of the University of Alberta (CA) 2007-12-12 — — EP disclosed
WO-2006096970-A1 SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2006-09-21 — — WO disclosed
Send feedback